Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis

Item

http://www.wikidata.org/entity/Q37108266

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vinflunine treatment in patien ...... ospective multicenter analysis

@en

Vinflunine treatment in patien ...... spective multicenter analysis.

@nl

type

Item

label

Vinflunine treatment in patien ...... ospective multicenter analysis

@en

Vinflunine treatment in patien ...... spective multicenter analysis.

@nl

prefLabel

Vinflunine treatment in patien ...... ospective multicenter analysis

@en

Vinflunine treatment in patien ...... spective multicenter analysis.

@nl

P1476

Vinflunine treatment in patien ...... ospective multicenter analysis

@en

P2093

Anders Ullén

http://www.w3.org/2001/XMLSchema#string

Carl-Henrik Shah

http://www.w3.org/2001/XMLSchema#string

Fredrik Jäderling

http://www.w3.org/2001/XMLSchema#string

Helle Pappot

http://www.w3.org/2001/XMLSchema#string

Karin Holmsten

http://www.w3.org/2001/XMLSchema#string

Line Dohn

http://www.w3.org/2001/XMLSchema#string

Niels Viggo Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology Group.

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy.

A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer.

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer.

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.

P304

1293-1300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4775

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446429

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4950730

http://www.w3.org/2001/XMLSchema#string